Literature DB >> 12815603

Prion susceptibility and protective alleles exhibit marked geographic differences.

Marta Soldevila1, Francesc Calafell, Aida M Andrés, Jordi Yagüe, Agnar Helgason, Kári Stefánsson, Jaume Bertranpetit.   

Abstract

A total of 616 chromosomes from control individuals of all major continental groups, and six individuals affected by either Creutzfeldt-Jakob disease (CJD) or fatal familial insomnia (FFI), were typed with a new single-reaction protocol method and were also sequenced, with total reproducibility to screen variation at important positions (385A>G: M129V and 655G>A: E219K) in the human prion protein gene (PRNP). We have found, for the first time, that 129V allele is highly represented in some populations from the Americas, and that 129M and 129V are in similar frequencies in Africa. The 129M susceptibility allele was found at high frequencies in Old World populations, very high in the Pacific ( approximately 81%) and up to 93% in Central and East Asia, but at a low frequency (approximately 30%) in Native Americans. The protective 219L allele was restricted to Asian and Pacific populations. Susceptibility alleles exhibit marked geographic differences in frequency, and thus, differences in probability to develop prion diseases. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815603     DOI: 10.1002/humu.9157

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  10 in total

1.  Variants associated with common disease are not unusually differentiated in frequency across populations.

Authors:  Kirk E Lohmueller; Matthew M Mauney; David Reich; John M Braverman
Journal:  Am J Hum Genet       Date:  2005-11-16       Impact factor: 11.025

2.  The prion protein gene in humans revisited: lessons from a worldwide resequencing study.

Authors:  Marta Soldevila; Aida M Andrés; Anna Ramírez-Soriano; Tomàs Marquès-Bonet; Francesc Calafell; Arcadi Navarro; Jaume Bertranpetit
Journal:  Genome Res       Date:  2005-12-20       Impact factor: 9.043

3.  Human F7 sequence is split into three deep clades that are related to FVII plasma levels.

Authors:  Maria Sabater-Lleal; José Manuel Soria; Jaume Bertranpetit; Laura Almasy; John Blangero; Jordi Fontcuberta; Francesc Calafell
Journal:  Hum Genet       Date:  2005-11-16       Impact factor: 4.132

4.  Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.

Authors:  Matthew T Bishop; Robert G Will; Jean C Manson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

5.  Characterization of variant Creutzfeldt-Jakob disease prions in prion protein-humanized mice carrying distinct codon 129 genotypes.

Authors:  Atsuko Takeuchi; Atsushi Kobayashi; James W Ironside; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  J Biol Chem       Date:  2013-06-21       Impact factor: 5.157

6.  Methods for high-density admixture mapping of disease genes.

Authors:  Nick Patterson; Neil Hattangadi; Barton Lane; Kirk E Lohmueller; David A Hafler; Jorge R Oksenberg; Stephen L Hauser; Michael W Smith; Stephen J O'Brien; David Altshuler; Mark J Daly; David Reich
Journal:  Am J Hum Genet       Date:  2004-04-14       Impact factor: 11.025

7.  Retrospective sequence analysis of the human PRNP gene from the formaldehyde-fixed paraffin-embedded tissues: report of two cases of Creutzfeldt-Jakob disease.

Authors:  J Sikora; A Srbová; F Koukolík; R Matej
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 8.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

Review 9.  An overview of human prion diseases.

Authors:  Muhammad Imran; Saqib Mahmood
Journal:  Virol J       Date:  2011-12-24       Impact factor: 4.099

10.  Iatrogenic Creutzfeldt-Jakob disease, final assessment.

Authors:  Paul Brown; Jean-Philippe Brandel; Takeshi Sato; Yosikazu Nakamura; Jan MacKenzie; Robert G Will; Anna Ladogana; Maurizio Pocchiari; Ellen W Leschek; Lawrence B Schonberger
Journal:  Emerg Infect Dis       Date:  2012-06       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.